Unknown

Dataset Information

0

Low-grade Serous Ovarian Carcinoma.

ABSTRACT: In the early 2000s a two-tier grading system was introduced for serous ovarian cancer. Since then, we have increasingly come to accept that low-grade serous ovarian carcinoma (LGSOC) is a separate entity with a unique mutational landscape and clinical behaviour. As less than 10% of serous carcinomas of the ovary are low-grade, they are present in only a small number of patients in clinical trials for ovarian cancer. Therefore the current treatment of LGSOC is based on smaller trials, retrospective series, and subgroup analysis of large clinical trials on ovarian cancer. Surgery plays a major role in the treatment of patients with LGSOC. In the systemic treatment of LGSOC, hormonal treatment and targeted therapies seem to play an important role.

SUBMITTER: Ricciardi E 

PROVIDER: S-EPMC6195427 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

In the early 2000s a two-tier grading system was introduced for serous ovarian cancer. Since then, we have increasingly come to accept that low-grade serous ovarian carcinoma (LGSOC) is a separate entity with a unique mutational landscape and clinical behaviour. As less than 10% of serous carcinomas of the ovary are low-grade, they are present in only a small number of patients in clinical trials for ovarian cancer. Therefore the current treatment of LGSOC is based on smaller trials, retrospecti  ...[more]

Similar Datasets

Unknown CAISMOV24, a new human low-grade serous ovarian carcinoma cell line.
| S-EPMC5683553 | biostudies-literature
Unknown KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma.
| S-EPMC4095747 | biostudies-other
Unknown The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features.
| S-EPMC7926503 | biostudies-literature
Unknown TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells.
| S-EPMC3419689 | biostudies-literature
Proteomics Multiomics Characterization of Potential Therapeutic Vulnerabilities in Low-grade Serous Ovarian Carcinoma
2021-05-17 | PXD019544 | Pride
Unknown Survival in women with grade 1 serous ovarian carcinoma.
| S-EPMC4870595 | biostudies-literature
Unknown PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas.
| S-EPMC2736318 | biostudies-literature
Unknown Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer.
| S-EPMC6500912 | biostudies-literature
Unknown Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study.
| S-EPMC7537352 | biostudies-literature
Unknown Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.
| S-EPMC4381406 | biostudies-literature